GLUT1 expression in high-risk prostate cancer: Correlation with 18F-FDG-PET/CT and clinical outcome

被引:0
|
作者
Pouliot, Frederic
Meizou, Salma
Goulet, Cassandra Ringuette
Hovington, Helene
Lefebvre, Veronique
Lavallee, Etienne
Bergeron, Michelle
Brisson, Herve
Champagne, Audrey
Neveu, Bertrand
Lacombe, Didier
Beauregard, Jean-Mathieu
Buteau, Francois-Alexandre
Riopel, Julie
机构
[1] Univ Laval, CHU Quebec, Canc Res Ctr, Quebec City, PQ, Canada
[2] Laval Univ, Quebec City, PQ, Canada
[3] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
291
引用
收藏
页数:1
相关论文
共 50 条
  • [1] GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
    Salma Meziou
    Cassandra Ringuette Goulet
    Hélène Hovington
    Véronique Lefebvre
    Étienne Lavallée
    Michelle Bergeron
    Hervé Brisson
    Audrey Champagne
    Bertrand Neveu
    Didier Lacombe
    Jean-Mathieu Beauregard
    François-Alexandre Buteau
    Julie Riopel
    Frédéric Pouliot
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 441 - 448
  • [2] GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
    Meziou, Salma
    Goulet, Cassandra Ringuette
    Hovington, Helene
    Lefebvre, Veronique
    Lavallee, Etienne
    Bergeron, Michelle
    Brisson, Herve
    Champagne, Audrey
    Neveu, Bertrand
    Lacombe, Didier
    Beauregard, Jean-Mathieu
    Buteau, Francois-Alexandre
    Riopel, Julie
    Pouliot, Frederic
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (03) : 441 - 448
  • [3] 18F-FDG-PET/CT in Prostate Cancer: is there any role?
    Gogou, L.
    Kehagias, D.
    Nikaki, A.
    Filippi, V.
    Vlachou, F.
    Efthimiadou, R.
    Gogos, K.
    Papoutsis, V.
    Andreou, I.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S276 - S277
  • [4] GLUT1 EXPRESSION IN HEPATOCELLULAR CARCINOMA: CORRELATION WITH 18F-FDG UPTAKE
    Brito, A. F.
    Abrantes, A. M.
    Pinto-Costa, C.
    Mamede, C.
    Matos, C.
    Rodrigues, M. C.
    Goncalves, A. C.
    Rodrigues, A.
    Sarmento-Ribeiro, A. B.
    Castro-Sousa, F.
    Botelho, M. F.
    Tralhao, J. G.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S84 - S84
  • [5] A Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT in the Cancer Staging of Locoregional Lymph Nodes
    Slouka, David
    Krcal, Jiri
    Kostlivy, Tomas
    Hrabacka, Petr
    Skalova, Alena
    Mirka, Hynek
    Topolcan, Ondrej
    Kucera, Radek
    IN VIVO, 2020, 34 (04): : 2029 - 2032
  • [6] THE ROLE OF 18F-FDG-PET/CT IN THYROID CANCER
    Syrigos, Kostas Nikolaos
    Liotsou, Theodora
    Tsagouli, Sophia
    Skoura, Lina
    Chatzioannou, S.
    Datseris, G.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S160 - S160
  • [7] Value of the 18F-FDG-PET/CT in the initial staging of patients with high-risk thyroid cancer with aggressive histological subtypes
    Colmenter, Luis Felipe
    Daryanani, Sunil
    Zuniga, Sergio
    Vilar, Javier
    INVESTIGACION CLINICA, 2024, 65 (02):
  • [8] 18F-FDG-PET/CT scanning-clinical usefulness beyond cancer
    Donnelly, S. C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2018, 111 (09) : 593 - 593
  • [9] Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer
    Albano, Domenico
    Familiari, Demetrio
    Gentile, Roberta
    Scalisi, Salvatore
    Midiri, Federico
    Messina, Marco
    Spada, Massimiliano
    Fornito, Maria C.
    Galia, Massimo
    Midiri, Massimo
    Alongi, Pierpaolo
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (08) : 741 - 746
  • [10] GLUT1 expression in tissue and 18F-FDG uptake
    Avril, N
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (06) : 930 - 932